Repeated administration of CGP 46381, a γ-aminobutyric acidB antagonist, and ethosuximide suppresses seizure-associated cyclic adenosine 3′5′ monophosphate response element- and activator protein-1 DNA-binding activities in lethargic (lh/lh) mice

Neuroscience Letters

Volumn 297, Issue 3, 2001, Pages 207-210

  Ishige, Kumiko ^a   Endo, Hitomi ^a   Saito, Hiroshi ^a   Ito, Yoshihisa ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Absence seizure; Activator protein 1 DNA; CGP 46381; Cyclic adenosine 3 5 monophosphate responsive element; Ethosuximide; Lethargic (lh lh) mouse

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; CGP 46381; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; ETHOSUXIMIDE; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ABSENCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BINDING AFFINITY; BRAIN CORTEX; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DRUG EFFECT; FEMALE; GENETIC MODEL; LETHARGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; SEIZURE; THALAMUS;

ANIMALS; ANTICONVULSANTS; CEREBELLUM; CEREBRAL CORTEX; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPILEPSY, ABSENCE; ETHOSUXIMIDE; GABA ANTAGONISTS; HIPPOCAMPUS; MICE; PHOSPHINIC ACIDS; RECEPTORS, GABA-B; SLEEP STAGES; THALAMUS; TRANSCRIPTION FACTOR AP-1; TREATMENT OUTCOME;

EID: 0035910643     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01702-X     Document Type: Article

References (19)

1. Pharmacological profiles of generalized absence seizures in lethargic, stargazer and γ-hydroxybutyrate-treated model mice
2. B receptor antagonists: From synthesis to therapeutic applications
3. 2+ channel β subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse
4. B receptors in excitation and inhibition of thalamocortical cells
5. Catalog of mutant genes and polymorphic loci
6. B receptor activation in absence seizures of lethargic (lh/lh) mice
7. B receptors regulate absence seizures in the lethargic (lh/lh) mouse model
8. Neuronal circuitry of thalamocortical epilepsy and mechanisms of antiabsence drug action
9. γ-Butyrolactone-induced absence-like seizures increase nuclear CRE- and AP-1 DNA-binding activities in mouse brain
10. Pharmacological profiles of γ-butyrolactone-induced increases in CRE- and AP-1 DNA-binding activities in a mouse absence seizure model
11. Characterization of absence seizure-dependent cyclic AMP responsive element- and activator protein 1 DNA-binding activities in lethargic (lh/lh) mice
12. B antagonists block γ-butyrolactone-induced absence seizures and coordinated induction of transcription factors in mouse brain
13. B neurotransmission in the control of absence seizures in the rat
14. Human absence epilepsies
15. Regulation of cAMP-inducible genes by CREB
16. DNA binding activities of three murine Jun proteins: Stimulation by Fos
17. Kainate-induced changes in opioid peptide genes and AP-1 DNA expression in the rat hippocampus
18. Pharmacological regulation of AP-1 transcription factor DNA binding activity
19. Basic mechanisms of generalized absence seizures